Henrietta Fore - Director, Theravance Biopharma, Inc

As of August 11, 2017


What is Henrietta Fore's Net Worth?

The current estimated net worth of Theravance Biopharma, Inc's Director, Henrietta Fore, is estimated to be about $5.84M . Henrietta Fore owns about 24,000 units of Theravance Biopharma, Inc common stock. In the last 3 years at Theravance Biopharma, Inc, Henrietta Fore has sold an estimated value of $0 worth.

What is Henrietta Fore's Past Insider Trading?

Henrietta Fore's largest purchase order was 6,000 units , worth over $143.93K on August 11, 2017. In total, Henrietta Fore has made about 5 transactions over 3 years of their time at Theravance Biopharma, Inc. Henrietta Fore usually trades in May, with the busiest year in 2017.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Henrietta Fore's' Mailing Address?

  • Mailing address is Theravance, Inc. 901 Gateway Blvd. South San Francisco CA 94080 CA

Theravance Biopharma, Inc Executive Compensation

Name
Year
Salary
Bonus
Other Earnings Plans or Compensations
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Rick E Winningham 2020 $1,014,455 - $579,646 - $579,646 $6,045 $6,577,746
Rick E Winningham 2019 $983,710 - $473,906 - $473,906 $5,496 $5,932,411
Rick E Winningham 2018 $956,600 $74,767 $690,154 - $690,154 $5,000 $2,522,841
Andrew A. Hindman 2020 $551,608 - $265,278 - $265,278 $5,920 $2,097,950
Andrew A. Hindman 2019 $315,000 $175,000 $216,000 $2,204,956 $216,000 - $3,757,956
Brett Haumann 2020 $572,569 - $213,589 - $213,589 $53,267 $2,742,625
Brett Haumann 2019 $543,047 - $170,000 - $170,000 $42,382 $2,464,280
Brett Haumann 2018 $497,810 $34,125 $315,000 - $315,000 $414,300 $1,517,194
Vijay Sabesan 2020 $407,677 - $760,326 - $760,326 $6,541 $3,077,744
Bradford J. Shafer 2020 $556,321 - $264,999 - $264,999 $6,045 $2,730,565
Bradford J. Shafer 2019 $537,403 - $215,611 - $215,611 $6,983 $2,468,848
Bradford J. Shafer 2018 $518,080 $33,770 $311,726 - $311,726 $5,000 $1,124,537
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1583107/000110465921039784/tm212357-1_def14a.htm

What are Theravance Biopharma, Inc's Past Insider Trades?

Theravance Biopharma, Inc's most recent insider trade came on May 24, 2022 by Rhonda Farnum who sold 3,281 units worth $28.88K . In the last 7 years, insiders at Theravance Biopharma, Inc have sold an estimated value of $52.4M and bought an estimated value of $26.3M worth of shares. Insider trading is most common in February, with the busiest year in 2018. The most active traders at the company are Bradford Shafer, EVP,  Rick Winningham, CHIEF EXECUTIVE OFFICER,  and Philip Worboys, SVP .

Theravance Biopharma, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1